India may get its first dengue vaccine within the first half of 2025. Japanese drugmaker Takeda's QDENGA has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO). Takeda has partnered…
India's drug regulator has moved toward allowing generic lenacapavir, a twice-yearly injectable HIV prevention drug, by recommending waiver of local Phase 3 clinical trials for Dr Reddy's Laboratories and Emcure Pharmaceuticals. The…
India's Union Health Ministry has directed that all fixed-dose combinations (FDCs) containing chlorpheniramine maleate and phenylephrine hydrochloride must carry a label warning against use in children below four years. The Drugs Technical…
The Drugs Controller General of India (DCGI) plans to intensify audits of medical device manufacturing facilities to check compliance with prescribed norms, Dr Rajeev Raghuvanshi announced at the CII Global MedTech Summit.…
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and Union territory drug controllers to ensure that medicines containing enclomiphene and its combinations are not manufactured, sold or distributed in…
A new study published in the European Journal of Ophthalmology has found that a smartphone-based AI system demonstrated high accuracy in detecting major eye diseases including diabetic retinopathy, age-related macular degeneration and…
Mumbai-based healthtech startup Butterfly Learnings has raised Rs 65 crore ($7.7 million) in a pre-Series B funding round led by Inflexor Ventures. Existing investors Enzia Ventures, Insitor Impact Asia Fund and IIMA…
Sree Chitra Tirunal Institute for Medical Sciences and Technology has unveiled Chitra Core, its first coronary stent, at a conference in New Delhi. The polymer-coated Everolimus drug-eluting stent uses a Cobalt-Chromium alloy…
India's drug regulator has clarified that new drugs not yet approved anywhere in the world must undergo the full domestic regulatory process, even if Indian patients participated in global clinical trials. The…
The CBI has registered a corruption case against Bikash Roy, assistant drug controller at the CDSCO sub-zonal office in Visakhapatnam, and H Vikram, managing director of Artura Pharmaceuticals, over an alleged bribery…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.